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Interferon-g is a potent inducer of growth arrest
and squamous differentiation of human epidermal
keratinocytes in vitro. In order to understand the proxi-
mate events regulating interferon-g action we studied
the relationship between interferon-g-mediated induc-
tion of a cytoplasmic guanylate-binding protein and the
expression of growth and differentiation marker genes
in normal and transformed keratinocytes. Induction of
guanylate-binding protein mRNA by interferon-g was
detectable at 4 h, was transcription dependent, and
preceded changes in the expression of markers of
growth arrest (E2F-1 mRNA downregulation) and dif-
ferentiation (SQ37 mRNA induction). The Ec50 value
for guanylate-binding protein induction (4 units inter-
feron-g per ml) was lower than previously reported for
SQ37 (40 units interferon-g per ml). Guanylate-binding
protein mRNA appeared to be only moderately down-
regulated by modulators of the squamous phenotype
such as retinoic acid and transforming growth factor-
b1. In addition, mRNA levels of E2F-1 or SQ37 were
The pathway of squamous differentiation is a multistepprocess common to epithelia of many origins. Ourlaboratory is interested in the events regulating squam-ous differentiation in normal tissues (Smits et al, 1987;Jetten et al, 1992; Marvin et al, 1992; Saunders et al,
1993) as well as the dysregulation that occurs in squamous carcinoma
cells (Jetten et al, 1990; Nervi et al, 1990; Vollberg et al, 1992;
Jones et al, 1997). Squamous differentiation is characterized by
irreversible growth arrest of a basal cell followed by the expression
of various squamous-specific marker genes such as transglutaminase
type I (Jetten and Shirley, 1986; Floyd and Jetten, 1989; Saunders
et al, 1993), cornifin (Smits et al, 1987; Marvin et al, 1992), relaxin
(Jetten et al, 1992), loricrin (Hohl et al, 1991), involucrin (Rice
and Green, 1979), and keratins 1 and 10 (Kopan and Fuchs, 1989).
Proliferation and differentiation in the epidermis is regulated by
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not altered in several squamous carcinoma cell lines
treated with interferon-g. In contrast, guanylate-bind-
ing protein mRNA was highly induced in all these cell
lines following interferon-g treatment. Further analysis
of the signal transduction pathway mediating inter-
feron-g responses using protein kinase inhibitors indi-
cated that guanylate-binding protein induction in
normal human epidermal keratinocyte cells was most
likely protein kinase C independent. Our data suggest
that more than one postreceptor interferon-g signaling
pathway exists in keratinocytes and that at least one
of these pathways is defective in squamous carcinoma
cells. Furthermore, our data demonstrated that the
failure of the squamous carcinoma cells to undergo
interferon-g-induced growth arrest and differentiation
is not due to an inherent defect in interferon-g receptor
activation, but most likely is due to a defect in a non-
guanylate-binding protein-dependent signaling path-
way. Key words: cancer/epithelium/squamous differentiation.
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many cytokines. For instance, interferon (IFN) -γ; Nickoloff et al,
1986; Schuger et al, 1990; Saunders and Jetten, 1994), interleukin-6
(Sehgal and Gottlieb, 1989), transforming growth factor (TGF) -α
(Nickoloff et al, 1989), TGF-β (Vollberg et al, 1991) and activation
of protein kinase C (Jetten et al, 1989a; Dlugosz and Yuspa, 1993)
have all been implicated as modulators of epidermal differentiation.
Most recently it has been reported that IFN-γ can induce growth
arrest and the expression of squamous differentiation marker genes
in a time-dependent and concentration-dependent manner in
epidermal keratinocytes (Saunders and Jetten, 1994). In addition,
abnormal control of some of these modulators has been associated
with various pathologic states. For instance, the IFN-γ receptor
and TGF-α show aberrant patterns of expression in psoriasis (Mitra
and Nickoloff, 1992; Scheynius et al, 1992). In addition, many
squamous carcinoma cell lines have been shown to be resistant to
growth-inhibitory agents such as phorbol esters (Jetten et al, 1989a)
or TGF-β1 (Reiss et al, 1993). Thus, transformation of normal
epidermal cells to the neoplastic phenotype is associated with
changes in their responsiveness to a broad range of growth-
inhibitory and differentiation-inducing stimuli. An earlier report
from this laboratory indicated that several squamous carcinoma cell
lines were nonresponsive to the growth inhibition and differenti-
ation induced by IFN-γ (Saunders and Jetten, 1994). This study
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begins to examine at what point in the IFN-γ signaling pathway
the defect may occur.
Previously, a signal transduction pathway for IFN-γ action has
been described in fibroblasts. Shuai et al (1992) demonstrated that
the binding of IFN-γ to its cognate receptor results in tyrosine
phosphorylation of a 91 kDa cytoplasmic factor (GAF or STA1α;
Decker et al, 1991). Phosphorylated GAF then translocates to the
nucleus and binds to an IFN-γ activating sequence (GAS) in the
promoter of IFN-γ inducible genes such as guanylate-binding
protein (GBP). GBP (p67) is a cytoplasmic GBP of unknown
function that is rapidly induced by IFN-γ in several cell types
(Cheng et al, 1991; Bandopadhyay et al, 1992; Shuai et al, 1992).
An understanding of the proximate effects of IFN-γ in normal
human epidermal keratinocyte cells may lead to an understanding
of the normal regulation of proliferation and differentiation in these
cells. Therefore, we compared the regulation of GBP expression
in IFN-γ-treated normal human epidermal keratinocytes with the
action of IFN-γ on growth and differentiation-specific genes. In
addition, we examined GBP expression in several transformed
keratinocyte cell lines and squamous carcinoma cell lines that are
resistant to the growth-inhibitory and differentiation-inducing
action of IFN-γ. Our data indicate that multiple IFN-γ-signaling
pathways exist in keratinocytes and that at least one of these is
defective in squamous carcinoma cells.
MATERIALS AND METHODS
Cell culture Second passage normal human epidermal keratinocytes
were obtained from Clonetics (San Diego, CA). Squamous carcinoma cell
lines SCC13, and SQCC/Y1 were a gift from Dr. Rheinwald (Harvard
University, Cambridge, MA) and Dr. McLane (Hoffmann-La Roche,
Nutley, NJ), respectively. The SV-40-T transformed human epidermal
keratinocyte cell line SV-K14 (K14) was a gift from Dr. Michel (CIRD
Galderma, Sophia Antipolis, France). All cells used in this study were
cultured in keratinocyte growth medium (Clonetics) supplemented with
1 mg protein per ml (final concentration) bovine pituitary extract and
grown at 37°C in a 5% CO2 atmosphere. Recombinant human TGF-β1,
recombinant human IFN-γ and recombinant human IFN-α were obtained
from R&D systems (Minneapolis, MN) and stocks were made in 0.1%
bovine serum albumin in phosphate-buffered saline (137 mM NaCl,
2.7 mM KCl, 4.3 mM Na2HPO4, 1.4 mM KH2PO4, pH 7.3) and
stored at 4°C. Cycloheximide (Sigma, St. Louis, MO) was solubilized in
phosphate-buffered saline and used at a final concentration of 2.5 µg per
ml. Actinomycin D was solubilized in dimethyl sulfoxide and used at a
final concentration of 250 ng per ml.
RNA isolation and northern blot analysis Cells were grown on
150 mm dishes and after the appropriate treatment the RNA was isolated
by centrifugation of a guanidinium isothiocyanate cell lysate through a
discontinuous CsCl gradient (Sambrook et al, 1989). Northern blots were
prepared by the transfer of RNA fractionated on a 1.2% denaturing agarose
gel to nylon membranes (Nytran, Schleicher and Schuell, Keene, NH).
The cDNA for human GBP (p67) was a kind gift of Dr. Berish Rubin
(Fordham University, NY) and a probe was prepared by the amplification
of the insert from the TAR cloning vector (InVitrogen, San Diego,
CA) using vector primers. Transglutaminase type I probe was made by
amplification of the insert from the pBluescript cloning vector (Stratagene,
La Jolla, CA) as described (Saunders et al, 1993). SQ37 cDNA probe was
obtained by the EcoRI digestion of the cDNA insert from pMG-5 (Smits
et al, 1987). A probe for glyceraldehyde-3-phosphate dehydrogenase (GAD)
was prepared by restriction digestion as described (Saunders et al, 1993).
Cloning of the E2F-1 cDNA used 20 bp primers complementary to
bases 423–443 bp (TGACCATCAGTACCTGGCCG) and 1360–1380 bp
(AGGCCGAAGTGGTAGTCGAG) of the previously published sequence
for E2F-1 (Helin et al, 1992; Kaelin et al, 1992). The cDNA was obtained
by amplification from single-stranded cDNA prepared from human fetal
lung mRNA (Clontech, Palo Alto, CA) using the ss-cDNA synthesis kit
(InVitrogen). The amplified product was cloned into the TAR cloning
vector (InVitrogen) and probe amplification used vector primers. The
identity of the product was confirmed by sequencing (Sequenase, United
States Biochemical; Cleveland, OH). All amplified probes or restriction
fragments were gel purified before use and were labeled by random primer
labeling (BRL, Gaithersburg, MD) to a specific activity of 5 3 108–
2 3 109 cpm [32P] per µg DNA. Prehybridization and hybridization
conditions have been previously described (Saunders et al, 1993) and blots
were washed at a final stringency of 0.2 3 sodium citrate/chloride
buffer 1 0.1% sodium dodecyl sulfate at 60°C (1 3 sodium citrate/
chloride buffer 5 150 mM NaCl, 15 mM Na citrate, pH 7.0).
Protein and western blotting Cells were grown in 60 mm dishes and
following appropriate treatment were washed with phosphate-buffered
saline containing 1 mM ethylene diamine tetraacetic acid and then scraped
into sample buffer (7% glycerol, 0.5 mM ethylene diamine tetraacetic acid,
1 mM phenylmethylsulfonyl fluoride, 2% sodium dodecyl sulfate, 10 mM
dithiothreitol, 60 mM Tris–HCl pH 6.8). Protein was determined by a
modified Lowry method (Dc protein assay, BioRad, Hercules, CA). Equal
amounts of protein (20 µg) were loaded on 10–20% sodium dodecyl
sulfate–polyacrylamide gel electrophoresis gradient gels (Integrated Separa-
tion Systems, Natick, MA). Gels were blotted on to nitrocellulose and
incubated with either antibodies to cornifin (1:1000, SQ37-b) or 1:500
rabbit anti-human GBP (a generous gift from Dr. Cheng, DuPont,
Wilmington, DE) or rabbit anti-human cdc2 (5 µg per ml; no. 05–161
Upstate Biotechnology Inc., Lake Placid, NY). Immunodetection of SQ37
and GBP used [125I] labeled protein A (30 mCi per mg, 0.075 µCi per
ml; Amersham, Arlington Heights, IL) whereas cdc2 immunoreactivity
was visualized using chemiluminescence (ECL; Amersham). IFN-γ dose–
response profiles for GBP protein levels were quantitated by scanning laser
densitometry and subsequent analysis with the GSXL2 software package
(Pharmacia LKB; Piscataway, NJ).
DNA synthesis assay The proliferative capacity of keratinocyte cultures
was estimated by the incorporation of [3H] thymidine ([3H]methyl thymid-
ine; 5.0 mCi per mmol; Amersham). Cells were grown on 35 mm dishes
or 25 mm wells. At the appropriate times cells were incubated with 2.5 µCi
per ml of [3H]thymidine for 3 h at 37°C. Cells were washed with cold
phosphate-buffered saline and then incubated with 1 ml of acid alcohol
(90% methanol/10% acetic acid) for 1 h at 4°C. Cells were solubilized in
0.5 ml 0.2 M NaOH at 37°C for 30 min and neutralized with 0.5 ml
0.5 M HCl. Aliquots were taken for liquid scintillation counting and
protein determination. We have previously established that in normal
human epidermal keratinocyte cells [3H]thymidine incorporation correlates
with colony-forming efficiency, cell number, and the expression of
proliferation-associated genes (Saunders et al, 1994).
RESULTS
Time-dependent and concentration-dependent IFN-g-
mediated GBP expression in human keratinocytes
Treatment of normal human epidermal keratinocytes with
1000 units per ml of recombinant human IFN-γ resulted in an
increase in GBP mRNA that was measurable at 4 h and maximal
at 12 h (Fig 1A). This correlated with a 61% and 83% decrease in
DNA synthesis below that of untreated controls. The increase in
GBP mRNA decreased between 12 and 36 h (Fig 1A). The
induced level of GBP mRNA preceded both the downregulation
of the proliferation-associated gene E2F-1 as well as the induction
of the differentiation marker SQ37 (Fig 1A). The induction of
GBP protein by IFN-γ occurred later than the induction of the
mRNA (Fig 1B). An increase in GBP protein was first detected
at 12 h and in contrast to the mRNA was further increased by
36 h (Fig 1B). Induction of SQ37 protein levels was evident
following 36 h IFN-γ treatment (Fig 1B). A moderate downregul-
ation of cdc2 protein was evident 36 h after IFN-γ treatment
(Fig 1B). In contrast, cdc2 mRNA downregulation, e.g., E2F-1
mRNA, occurs after 12 h (Saunders et al, 1994). We extended the
time-dependent studies to a comparison of the kinetics of GBP
protein induction with previously established values for [3H]
thymidine incorporation, transglutaminase type I and SQ37 induc-
tion by IFN-γ (Saunders et al, 1994). The effective concentration
at which a half maximal response was observed (Ec50) was µ 4 units
IFN-γ per ml for GBP (Fig 2). This is lower than previously
published for [3H] thymidine incorporation, SQ37 or transglutamin-
ase type I (20–50 units IFN-γ per ml; Saunders et al, 1994), which
suggests that the mechanism of IFN-γ action may be different for
GBP than for other markers.
Protein synthesis independence and specificity of IFN-g
action IFN-γ action has been shown to be protein synthesis
dependent in HeLa cells (Lew et al, 1989) and protein synthesis
independent in fibroblasts (Decker et al, 1989). Treatment of normal
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Figure 1. Time-dependent action of IFN-γ action in human
keratinocytes. (A) Northern blot of changes in GBP mRNA expression
at various intervals following treatment of preconfluent cultures of human
keratinocytes with IFN-γ (1000 units per ml) for 36 h. For reference
the mRNA expression of differentiation marker cornifin (SQ37) and
proliferation-associated gene (E2F-1) is provided. Normalization for loading
inequalities is provided by comparison with GAD expression. Thirty
micrograms of total RNA was used in all lanes. (B) Total cellular protein
was extracted from preconfluent cultures of human keratinocytes at various
times following IFN-γ treatment (1000 units per ml). Twenty micrograms
of protein was electrophoresed and blotted. A western blot of changes in
GBP expression is shown. For comparison changes in cdc2 (proliferation)
and SQ37 (differentiation) are also shown.
Figure 2. Concentration-dependent induction of GBP protein
expression. Subconfluent cultures of normal human epidermal
keratinocyte cells were treated with varying concentrations of IFN-γ for
36 h. GBP protein was detected by immunoblotting and densitometry of
the exposed film. Data are presented as arbitrary densitometer units.
Figure 3. Protein synthesis independence and transcriptional
dependence of GBP mRNA induction. Normal human epidermal
keratinocyte cells were pretreated for 1 h with vehicle (–), 2.5 µg per ml
cycloheximide (Chx) or 250 ng per ml actinomycin D (Actino D) followed
by an 8 h treatment with 300 units IFN-γ per ml (IFN-γ) as appropriate.
Total RNA was extracted and 30 µg total RNA electrophoresed and
blotted. GBP mRNA expression is shown. GAD mRNA expression is
shown for comparison of loading inequalities.
human epidermal keratinocyte cells with either 250 ng per ml
actinomycin D or 2.5 µg per ml cycloheximide for 8 h results in
a 95% decrease in [35S] UTP or [35S] methionine incorporation,
respectively (Vollberg et al, 1991; Saunders et al, 1998). When
proliferating normal human epidermal keratinocyte cells were
pretreated with either actinomycin D or cycloheximide for 1 h
followed by an 8 h treatment with 300 units IFN-γ per ml
(Fig 3), induction of GBP mRNA by IFN-γ was not affected by
cycloheximide treatment but was abolished by actinomycin D
(Fig 3). These data indicate that protein synthesis is not required
for the induction of GBP mRNA in human keratinocytes and
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Figure 4. Specificity of IFN-γ action in normal human epidermal
keratinocyte cells. Preconfluent cultures of normal human epidermal
keratinocyte cells were treated for 36 h with TGF-β1 (100 pM), IFN-α
(300 units per ml), phorbol ester (TPA, 80 nM per ml), IFN-γ (300 units
per ml) or no treatment (proliferation). Total RNA was extracted and
30 µg total RNA electrophoresed and blotted. The expression of GBP
mRNA is shown as is the differentiation marker SQ37. The expression of
IFN-γ receptor mRNA is also shown (IF[capnu]γ rec). Normalization for
loading is provided by comparison with GAD mRNA expression.
suggests that the induction is due to transcriptional activation of
the GBP gene. Transcriptional activation of the GBP gene has
been previously reported for IFN-γ treated fibroblasts (Decker
et al, 1989).
To better understand the specificity of IFN-γ action, we wished
to determine if GBP was inducible by other known growth-
inhibitory and differentiation-inducing agents. We previously
showed that TGF-β1 treatment can induce reversible growth arrest
whereas treatment with the phorbol ester, 12-O-tetradecanoyl-
phorbol-13-acetate (TPA), results in irreversible growth arrest and
squamous differentiation (Jetten et al, 1989a; Saunders et al, 1993,
1994). GBP mRNA was not induced in TPA or TGF-β1 treated
normal human epidermal keratinocyte cells (Fig 4). The induction
of differentiation and growth arrest by TPA in the absence of GBP
induction indicates that GBP induction is not a prerequisite for
squamous differentiation. The specificity of IFN-γ induction of
GBP mRNA was further shown by the inability of IFN-α to
induce GBP or SQ37 mRNA after 36 h treatment (Fig 4). It was
recently reported that IFN-α could only induce GBP expression
transiently in HeLa cells (Lew et al, 1989). No induction of GBP
protein was observed, however, in normal human epidermal
keratinocyte cells during 8 h of IFN-α treatment (not shown).
IFN-γ action is mediated by specific, high-affinity receptors. The
IFN-γ-receptor mRNA level was not altered after treatment of
normal human epidermal keratinocyte cells with IFN-γ, the phorbol
ester TPA or by IFN-α or TGF-β1 treatment (Fig 4).
We previously reported that IFN-γ induction of differentiation
could be antagonized by TGF-β1 or retinoic acid (Saunders et al,
1994). Unlike TGF-β1, retinoic acid does not induce growth
arrest but similar to TGF-β1, does antagonize the expression of
differentiation markers (Saunders et al, 1994). TGF-β1 and retinoic
acid (RA) both had a moderate inhibitory effect (2-fold reduction)
on the induction of GBP mRNA by IFN-γ (Fig 5). IFN-γ
Figure 5. GBP mRNA expression is suppressed by modulators of
differentiation. Preconfluent normal human epidermal keratinocyte cells
were treated with 150 units IFN-γ per ml, 100 pM TGF-β1, 1 µM RA
or no treatment (Prolif.) either alone or in combination as shown.
RNA was extracted following a 36 h treatment and 30 µg total RNA
electrophoresed and blotted. GBP and transglutaminase type I (TGase I)
expression are shown as a northern blot. The regulation of differentiation
by TGF-β1 and RA is demonstrated by transglutaminase type I mRNA
expression. Densitometry of TGase I (black bar) and GBP (hatched bar)
expression is also shown normalized for GAD expression.
treatment induced the expression of transglutaminase type I mRNA
5-fold in this experiment (Fig 5) and this induction was inhibited
more than 90% by both TGF-β1 and RA. Combined, these data
demonstrate that GBP induction in keratinocytes is specific for
IFN-γ action and is only moderately suppressed by inhibitors of
squamous differentiation.
GBP expression in transformed epidermal cells and squam-
ous carcinomas cell lines The squamous carcinoma cell lines
SCC13, SV-K14 (K14) and SQCC/Y1 are not responsive to the
growth-inhibitory and differentiation-inducing properties of
IFN-γ even though they all express IFN-γ receptor mRNA
(Saunders et al, 1994). These results were confirmed by the
observation that in contrast to the normal cells, expression of
mRNA for the proliferation associated gene E2F-1 was not
suppressed by IFN-γ in any cell line (Fig 6). In addition, the
expression of the differentiation marker, SQ37, was inducible by
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Figure 6. GBP mRNA expression in squamous cell carcinoma cell
lines. Preconfluent cultures of normal human epidermal keratinocyte cells
and the various named cell lines were treated in the absence or presence
of 300 units IFN-γ per ml. Total RNA was extracted and 25 µg RNA
electrophoresed and blotted. mRNA expression of the proliferation-
associated gene E2F-1, the differentiation-specific gene SQ37 is also shown.
Normalization for loading inequalities is provided by comparison with
GAD mRNA expression. Portions of this figure have been presented in a
recent review article (Saunders et al, 1996).
IFN-γ in normal human epidermal keratinocyte cells but not in
SCC13 or SQCC/Y1 and only to a minor extent in the K14 cell
line (Fig 6). Previously, we showed that these cell lines did not
exhibit an increase in transglutaminase type I mRNA after IFN-γ
treatment (Saunders et al, 1994). Figure 6 demonstrates that GBP
was induced in all the cell lines in response to IFN-γ. These results
indicate that the IFN-γ receptors are functional and that a defect
in the IFN-γ-signaling pathway may lie distal to that of GBP
induction or that an alternative IFN-γ signal transduction path-
way exists.
Effects of protein kinase inhibitors on GBP expression H7
(Lew et al, 1989) and staurosporine (Shuai et al, 1992) inhibit GBP
expression in HeLa cells and fibroblasts, respectively. We therefore
examined the effect of these inhibitors on GBP expression and
compared their effects with other IFN-γ regulated genes in normal
human epidermal keratinocyte cells. H7 did not have an effect on
IFN-γ induction of GBP or SQ37 mRNA in normal human
epidermal keratinocyte cells (Fig 7A). In contrast, 30 nM stauros-
porine abolished IFN-γ-induced SQ37 mRNA expression but did
not inhibit GBP mRNA expression (Fig 7B). The protein kinase
C-inhibitory activity of these agents was confirmed by the inhibition
of TPA-induced transglutaminase type I protein by H7 (30 µM)
and staurosporine (30 nM) (not shown). These findings indicated
that the regulation of GBP mRNA expression in keratinocytes was
different to that reported for fibroblasts or HeLa cells. It also
provided strong evidence for a protein kinase C-independent
pathway of IFN-γ-mediated induction of GBP in keratinocytes.
This contrasts to the staurosporine sensitivity of the differentiation
marker SQ37.
DISCUSSION
IFN-γ specifically induced GBP protein and mRNA in normal
human epidermal keratinocytes. In addition, IFN-γ downregulated
expression of mRNA for the proliferation associated gene E2F-1
as well as inducing the mRNA for the squamous-specific genes
cornifin (SQ37) and transglutaminase type I. The signaling pathways
Figure 7. The effect of protein kinase inhibitors on IFN-γ action
in normal human epidermal keratinocytes. Preconfluent normal
human epidermal keratinocyte cells were treated with 100 units IFN-γ per
ml for 36 h with varying concentrations of (A) H7 or (B) staurosporine
(ST). RNA was then isolated, blotted and probed for GBP (j), SQ37 (d)
or transglutaminase type I (s). All data have been normalized against GAD
expression. Data are expressed as a percentage of the expression induced
by IFN-γ alone.
involved in GBP induction, however, differed significantly to those
involved in growth arrest and differentiation in several important
respects. First, the induction of GBP mRNA occurred more rapidly
than alterations in the mRNA for the differentiation-specific marker
SQ37 and the proliferation-associated marker E2F-1. In addition,
the induction of GBP appeared to be more sensitive to IFN-γ
(Ec50 5 4 units IFN-γ per ml) than the regulation of either
proliferation or differentiation markers (Ec50 5 20–50 units
IFN-γ per ml; Saunders et al, 1994). Secondly, TGF-β1 and RA
antagonized the induction of the differentiation-specific marker,
transglutaminase type I (more than 10-fold reduction) in IFN-γ-
treated normal human epidermal keratinocyte cells. In contrast,
GBP induction was only moderately affected (2-fold) by TGF-β1
or RA. The action of RA and TGF-β1 was not a nonspecific
transcription-suppressive effect because they have been shown to
induce collagen type IV in cultured keratinocytes (Vollberg et al,
1991; Saunders et al, 1994). Finally, GBP mRNA was induced by
IFN-γ in squamous carcinoma cells in the absence of other IFN-γ
responses such as growth arrest or differentiation.
The function of GBP is currently unknown. This study, however,
suggests that the induction of GBP is not a prerequisite for squamous
differentiation for the following reasons. IFN-γ induces GBP in
other cell types such as fibroblasts (Decker et al, 1989; Saunders
et al, 1994) and HeLa cells (Lew et al, 1989) without inducing
growth arrest or differentiation. Also, both protein kinase C
activation or confluence induce growth arrest and differentiation
in the absence of GBP induction. Moreover, staurosporine inhibits
SQ37 mRNA expression but does not inhibit GBP induction.
Although these data do not demonstrate unequivocally that GBP
induction is not required for IFN-γ-induced squamous differenti-
ation they appear to suggest that GBP is involved in other IFN-
γ-mediated activities in keratinocytes (e.g., immunoregulation;
Nickoloff and Turka, 1993; Saunders et al, 1994).
An important finding in this study was that several squamous
carcinoma cell lines which lack the ability to undergo growth
inhibition or differentiation still retain IFN-γ responsiveness with
respect to GBP induction. In IFN-γ-treated fibroblasts the induction
of GBP involves the phosphorylation and translocation to the
nucleus of the transcription factor GAF (Shuai et al, 1992). GAF
then binds to a GAS element in the GBP promoter inducing GBP
transcription (Shuai et al, 1992). The transcription-dependent
induction of GBP in keratinocytes in this study suggests a similar
series of events may occur in keratinocytes. IFN-γ-induced GBP
expression in normal human epidermal keratinocytes, however,
was not inhibited by H7 and staurosporine. Both H7 (Lew et al,
1989) and staurosporine (Shuai et al, 1992) are known antagonists
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of protein kinases and have been shown to inhibit GBP induction
in HeLa cells and fibroblasts, respectively. These data suggest
that different phosphorylation/dephosphorylation (if any) reactions
maybe involved in the IFN-γ-signaling pathway regulating GBP
expression in normal human epidermal keratinocytes compared
with that of other cell types. In addition, the events involved in
the IFN-γ signaling pathway appear to be different within the
normal human epidermal keratinocytes with respect to the response
examined (differentiation vs. GBP induction). This is exemplified
by the inhibition of IFN-γ-induced SQ37 expression by stauros-
porine in the absence of an effect on GBP induction.
The differences between the regulation of GBP induction and
the regulation of the proliferation-associated or differentiation-
specific genes in normal human epidermal keratinocyte and squam-
ous carcinoma cells are consistent with GBP expression being
regulated by a different IFN-γ signaling pathway. In addition, the
induction of GBP in squamous carcinoma cells in this study
indicates not only that the IFN-γ receptor is intact but that the
proximate postreceptor signaling pathway is also functional. The
defective signaling pathway present in the carcinoma cells yields
insights into the IFN-γ signaling pathway present in normal
human epidermal keratinocytes. For instance, the lack of IFN-γ
responsiveness in the squamous carcinoma cells may be due to a
divergence in signaling pathways following receptor activation.
This is consistent with multiple receptor-coupled transducers being
involved. Alternatively, this divergence may occur following a few
shared postreceptor signaling events. It has been previously shown
that at least two protein kinases (JAK1 and JAK2) are involved in
IFN-γ signal transduction (Silvennoinen et al, 1993). One of these
(JAK2) was specific for IFN-γ whereas the other (JAK1) was
involved in IFN-α and IFN-γ action (Silvennoinen et al, 1993). A
role for JAK2 in IFN-γ-induced gene expression in normal human
epidermal keratinocytes was not examined in this study. Regardless
of the exact signal transduction mechanism, our data reflect the
existence of multiple IFN-γ signaling pathways within keratinocytes
that mediate different biologic responses.
Because the squamous carcinoma cell lines used in this study are
also nonresponsive to other growth arrest stimuli such as protein
kinase C activation (Jetten et al, 1989a, b) it is tempting to speculate
that the defect in the signaling pathways resides in a common
regulatory event (Jones et al, 1997). On this basis one might predict
that the introduction of genes regulating IFN-γ responsiveness may
alleviate the lack of response to these growth inhibitory agents.
Reiss et al (1993) reported the converse experiment in which
murine keratinocytes were stably transfected with mutant p53
expression vectors and showed reduced TGF-β1-induced growth
suppression. Whether, mutant p53 activity can result in IFN-γ and
phorbol ester nonresponsiveness in the human squamous carcinoma
cell lines used in this report needs further study.
In summary, this is the first study to describe the induction of
GBP mRNA by IFN-γ in human keratinocytes. Comparison of
the induction of GBP and SQ37 suggested the existence of
multiple signaling pathways of IFN-γ action. Furthermore, this
study indicates that at least one of these pathways is defective in
squamous carcinoma cells.
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